GHRP-2 acetate

Investigated uses

• No adequately documented human investigated use for the exact catalog identity/formulation was identified; any vendor-promoted goals were excluded from evidence grading.

Mechanism and hypotheses

• GHRP-2 is a ghrelin/growth-hormone-secretagogue receptor agonist that can increase GH release in humans.
• Hypothesized: Anti-aging, recovery and body-composition benefits are not established approved outcomes.

Human evidence

• No qualifying controlled human efficacy study for the exact catalog identity/formulation was identified in this review. Limitations: This is a bounded search conclusion, not proof that no report exists; identity, language and indexing limitations may apply.

Safety highlights

• Endocrine/metabolic effects and immunogenicity are concerns.
• FDA notes serious adverse events reported in studies, including increased insulin requirements, infection, pancreatitis and deaths in critically ill subjects; causality was not established.

Regulatory context

No FDA-approved GHRP-2 drug was identified; FDA lists it among substances presenting significant compounding safety concerns.